These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24471703)

  • 1. Effects of acute and long-term typical or atypical neuroleptics on morphine-induced behavioural effects in mice.
    Hollais AW; Patti CL; Zanin KA; Fukushiro DF; Berro LF; Carvalho RC; Kameda SR; Frussa-Filho R
    Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):255-63. PubMed ID: 24471703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.
    Fukushiro DF; Carvalho Rde C; Ricardo VP; Alvarez Jdo N; Ribeiro LT; Frussa-Filho R
    Brain Res Bull; 2008 Sep; 77(2-3):124-8. PubMed ID: 18721669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol (but not ziprasidone) withdrawal enhances cocaine-induced locomotor activation and conditioned place preference in mice.
    Fukushiro DF; Alvarez Jdo N; Tatsu JA; de Castro JP; Chinen CC; Frussa-Filho R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):867-72. PubMed ID: 17368685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective action of an atypical neuroleptic on the mechanisms related to the development of cocaine addiction: a pre-clinical behavioural study.
    Marinho EA; Oliveira-Lima AJ; Wuo-Silva R; Santos R; Baldaia MA; Hollais AW; Longo BM; Berro LF; Frussa-Filho R
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):613-23. PubMed ID: 24345415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic effects of aripiprazole and ziprasidone with respect to p-glycoprotein substrate properties.
    Holthoewer D; Kirschbaum KM; Frisch J; Hiemke C; Schmitt U
    Pharmacopsychiatry; 2013 Jul; 46(5):175-80. PubMed ID: 23737243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.
    Celikyurt IK; Kayir H; Ulak G; Erden FB; Ulusoy GK; Uzbay TI
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):528-36. PubMed ID: 21168466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.
    Barghon R; Protais P; Colboc O; Costentin J
    Neurosci Lett; 1981 Nov; 27(1):69-73. PubMed ID: 6120489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis.
    Chatterjee M; Ganguly S; Srivastava M; Palit G
    Behav Brain Res; 2011 Jan; 216(1):247-54. PubMed ID: 20699106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
    Ali O; Haleem DJ; Saify ZS; Kamil N; Obaid R; Ahmed SW
    Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
    Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
    Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide-dopamine interactions. III. Cyclo(His-Pro) and persistence of dopaminergic supersensitivity on withdrawal from one year continuous neuroleptic treatment.
    Prasad C
    Schizophr Res; 1988; 1(6):411-5. PubMed ID: 2908706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potentiation of morphine-withdrawal jumping by clonidine is antagonized by m-chlorophenylpiperazine and not by haloperidol.
    van der Laan JW; Hillen FC
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):45-55. PubMed ID: 2879519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours.
    Onaolapo OJ; Paul TB; Onaolapo AY
    Metab Brain Dis; 2017 Oct; 32(5):1475-1489. PubMed ID: 28508340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates.
    Casey DE; Bruhwyler J; Delarge J; Géczy J; Liégeois JF
    Psychopharmacology (Berl); 2001 Sep; 157(3):228-35. PubMed ID: 11605077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.